D.C. Circuit Sides with Manufacturers in Latest 340B Contract Pharmacy Case
FDA Law Blog
MAY 30, 2024
Carole Johnson (consolidated cases), the Court found that the conditions set by Novartis and United Therapeutics on covered entities did not violate the 340B statute, although more restrictive conditions could violate the law. This decision may encourage more state-level efforts to adopt similar laws.
Let's personalize your content